Article
Glaucoma diagnosis and treatment in the era of precision medicine.
Pharmacogenomics - 1 Jan 2025
Labay-Tejado Sara, Brunet Mercè, Milla Elena
Abstract excerpt
Glaucoma is a chronic, degenerative eye disease for which personalized diagnostic and therapeutic biomarkers are still lacking. Precision medicine offers a promising strategy to improve glaucoma management, and pharmacogenomics may play a key role in optimizing treatment response, minimizing side effects, and enhancing adherence. Advances in genetics have introduced potential tools such as polygenic risk scores...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
